Inactive Instrument
Irwin Naturals Inc. Stock Canadian Securities Exchange
Stocks
IWIN
CA46414Q1054
Pharmaceuticals
OTC Markets Traded| Market Cap | 483K 420K 391K 359K 678K 46.11M 688K 4.61M 1.81M 22.95M 1.81M 1.77M 76.97M | P/E 2021 |
105x | P/E 2022 | -0.91x |
|---|---|---|---|---|---|
| Enterprise Value | 21.01M 18.26M 17M 15.61M 29.48M 2.01B 29.93M 200M 78.65M 999M 78.91M 77.18M 3.35B | EV / Sales 2021 |
0.13x | EV / Sales 2022 | 0.31x |
| Free-Float |
1.04% | Yield 2021 * |
-
| Yield 2022 | - |
| 3 years | 0.05 |  | 1.5 |
| 5 years | 0.05 | | 4.75 |
| 10 years | 0.05 | | 4.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CEO | Chief Executive Officer | 60 | 01/01/1994 |
Mark Green
DFI | Director of Finance/CFO | - | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CHM | Chairman | 60 | 01/01/1994 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Marche | Chief Executive Officer | 18,240 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 708K | |
| -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +0.88% | -0.81% | +40.08% | +33.81% | 349B | |
| -0.76% | -1.43% | +33.94% | +42.24% | 297B | |
| -7.26% | -6.71% | +7.97% | +10.31% | 264B | |
| +0.06% | -5.93% | -1.87% | -42.77% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| Average | -0.06% | -1.35% | +28.59% | +50.49% | 397.08B | |
| Weighted average by Cap. | +0.34% | -2.17% | +36.90% | +73.27% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 100M 87.23M 81.19M 74.54M 141M 9.58B 143M 957M 376M 4.77B 377M 369M 15.99B | 89.47M 77.78M 72.39M 66.47M 126M 8.54B 127M 853M 335M 4.25B 336M 329M 14.26B |
| Net income | 8.62M 7.49M 6.97M 6.4M 12.09M 822M 12.27M 82.17M 32.25M 409M 32.35M 31.64M 1.37B | -3.99M -3.47M -3.23M -2.97M -5.6M -381M -5.69M -38.07M -14.94M -190M -14.99M -14.66M -636M |
| Net Debt | 9.35M 8.13M 7.57M 6.95M 13.12M 893M 13.32M 89.2M 35.01M 444M 35.13M 34.35M 1.49B | 20.53M 17.84M 16.61M 15.25M 28.8M 1.96B 29.24M 196M 76.84M 976M 77.09M 75.4M 3.27B |
Employees
-
Sector
Pharmaceuticals
